Latest Share Chat

REMOVE ADS

Glaxosmithkline Share News (GSK)

Glaxosmithkline Information

Share Price Information for Glaxosmithkline (GSK)

Share Price is delayed by 15 minutes

Get Live Data

1,903.50 0.00 (0.00%)

Bid:

1,840.00

Ask:

1,999.00

Spread: 159.00 (8.641%)

Market Cap: £76.31b

Last checked at -

Intraday Glaxosmithkline Share Chart

REMOVE ADS

Glaxosmithkline News

LONDON BRIEFING: Stocks called up as market awaits US GDP figures

(Alliance News) - Stocks were called higher in London on Thursday morning, as investors wait for a handful of data from the US later, including the mo...

GSK;s RSV vaccine gets expanded approval in Europe

(Sharecast News) - GSK announced on Thursday that the European Commission had granted approval for Arexvy, a respiratory syncytial virus (RSV) vaccine...

FTSE 100 ends flat; miners, luxury stocks lead declines

FTSE 100 flat, FTSE 250 down 0.5% *

LONDON MARKET CLOSE: Mixed trade before Nvidia takes centre-stage

(Alliance News) - Stock prices in Europe closed mixed on Wednesday, while equities in New York traded in a nervy fashion, as investors anxiously await...

GSK not clear from "Zantac overhang" but latest US ruling positive

(Alliance News) - While Zantac worries are not completely resolved, the latest bit of good news for GSK PLC should give investors some reassurance, an...

London close: Stocks slip as investors await Nvidia results

(Sharecast News) - London stocks ended slightly down on Wednesday, with investors showing restraint ahead of crucial earnings from US chipmaker Nvidia...

Shore Capital hails "another ray of light" at GSK after Zantac litigation update

(Sharecast News) - Shore Capital has reiterated its 'buy' rating on GSK after the biopharma giant's latest update about its ongoing Zantac litigation,...

TOP NEWS: GSK hails approval in Japan; US court decision on Zantac

(Alliance News) - GSK PLC on Wednesday announced progress in Japan on treating chronic hepatitis B and chronic rhinosinusitis with nasal polyps, while...